News
Filters
Showing 1 - 10 out of 21 results
Article
FOX 4: Saint Luke's Neurologist Discusses Migraine Prevention, Treatment
Robert Reddig, MD, neurologist at Saint Luke's Marion Bloch Neuroscience Institute, joined FOX 4's Afternoon Drive to break down what you need to know about migraines.
Patient Stories
A Heart Care Experience to Remember: For a Kansas Citian With a History of Heart Issues, the Proactive, Personable Care at Saint Luke’s Stood Out
Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.
News
KMBC: New Heart Procedure at Saint Luke’s Gives Hope to Patient With Decades-long Heart Issues
After years of life-threatening cardiac episodes and chest pain, Cindy Mager, 59, became the first Saint Luke's patient to undergo this innovative, life-saving procedure.
News
CNN: Survival Rates Far Worse for Black Women After Bystander CPR, Study Finds
Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.
Article
USA Today: Black People, Women Less Likely to Survive After CPR for Cardiac Arrest
USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.
Article
Health News You Can Use: Alzheimer’s Disease Prevention and Treatment
Nearly 7 million people in the U.S. are living with Alzheimer’s disease. That number is expected to double by the year 2060.
News
FOX4: Overland Park Stroke Survivor Works to Help Others with Depression and Anxiety After Stroke
After suffering a stroke at the age of 46, one local woman is working to help others struggling with depression and anxiety after having a stroke.
News
FDA Approves PulseSelect Pulsed Field Ablation System, a Novel Treatment for Atrial Fibrillation
Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.
News
Cardiovascular Business: TAVR Linked to Favorable Outcomes for Asymptomatic and Minimally Symptomatic Patients—But is it Necessary?
TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.
News
diaTribe Learn: The Future of Cardiometabolic Care
Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.